Sentences with phrase «other advanced clinical»
Medical residents and other advanced clinical trainees often have to find abortion training and experience in settings outside of their educational program.
https://www.sciencedaily.com/ Not exact matches
This is an incredibly difficult question to answer for a variety of reasons, most importantly because over the years our once vaunted «beautiful» style of play has become a shadow of it's former self, only to be replaced by a less than stellar «plug and play» mentality where players play out of position and adjustments / substitutions are rarely forthcoming before the 75th minute... if you look at our current players, very few would make sense in the traditional Wengerian system... at present, we don't have the personnel to move the ball quickly from deep - lying position, efficient one touch midfielders that can make the necessary through balls or the disciplined and pacey forwards to stretch defences into wide positions, without the aid of the backs coming up into the final 3rd, so that we can attack the defensive lanes in the same clinical fashion we did years ago... on this current squad, we have only 1 central defender on staf, Mustafi, who seems to have any prowess in the offensive zone or who can even pass two zones through so that we can advance play quickly out of our own end (I have seen some inklings that suggest Holding might have some offensive qualities but too early to tell)... unfortunately Mustafi has a tendency to get himself in trouble when he gets overly aggressive on the ball... from our backs out wide, we've seen pace from the likes of Bellerin and Gibbs and the spirited albeit offensively stunted play of Monreal, but none of these players possess the skill - set required in the offensive zone for the new Wenger scheme which requires deft touches, timely runs to the baseline and consistent crossing, especially when Giroud was playing and his ratio of scored goals per clear chances was relatively low (better last year though)... obviously I like Bellerin's future prospects, as you can't teach pace, but I do worry that he regressed last season, which was obvious to Wenger because there was no way he would have used Ox as the right side wing - back so often knowing that Barcelona could come calling in the off - season, if he thought otherwise... as for our midfielders, not a single one, minus the more confident Xhaka I watched played for the Swiss national team a couple years ago, who truly makes sense under the traditional Wenger model... Ramsey holds onto the ball too long, gives the ball away cheaply far too often and abandons his defensive responsibilities on a regular basis (doesn't score enough recently to justify): that being said, I've always thought he does possess a little something special, unfortunately he thinks so too... Xhaka is a little too slow to ever boss the midfield and he tends to telegraph his one true strength, his long ball play: although I must admit he did get a bit better during some points in the latter part of last season... it always made me wonder why whenever he played with Coq Wenger always seemed to play Francis in a more advanced role on the pitch... as for Coq, he is way too reckless at the wrong times and has exhibited little offensive prowess yet finds himself in and around the box far too often... let's face it Wenger was ready to throw him in the trash heap when injuries forced him to use Francis and then he had the nerve to act like this was all part of a bigger Wenger constructed plan... he like Ramsey, Xhaka and Elneny don't offer the skills necessary to satisfy the quick transitory nature of our old offensive scheme or the stout defensive mindset needed to protect the defensive zone so that our offensive players can remain aggressive in the final third... on the front end, we have Ozil, a player of immense skill but stunted by his physical demeanor that tends to offend, the fact that he's been played out of position far too many times since arriving and that the players in front of him, minus Sanchez, make little to no sense considering what he has to offer (especially Giroud); just think about the quick counter-attack offence in Real or the space and protection he receives in the German National team's midfield, where teams couldn't afford to focus too heavily on one individual... this player was a passing «specialist» long before he arrived in North London, so only an arrogant or ignorant individual would try to reinvent the wheel and / or not surround such a talent with the necessary components... in regards to Ox, Walcott and Welbeck, although they all possess serious talents I see them in large part as headless chickens who are on the injury table too much, lack the necessary first - touch and / or lack the finishing flair to warrant their inclusion in a regular starting eleven; I would say that, of the 3, Ox showed the most upside once we went to a back 3, but even he became a bit too consumed by his pending contract talks before the season ended and that concerned me a bit... if I had to choose one of those 3 players to stay on it would be Ox due to his potential as a plausible alternative to Bellerin in that wing - back position should we continue to use that formation... in Sanchez, we get one of the most committed skill players we've seen on this squad for some years but that could all change soon, if it hasn't already of course... strangely enough, even he doesn't make sense given the constructs of the original Wenger offensive model because he holds onto the ball too long and he will give the ball up a little too often in the offensive zone... a fact that is largely forgotten due to his infectious energy and the fact that the numbers he has achieved seem to justify the means... finally, and in many ways most crucially, Giroud, there is nothing about this team or the offensive system that Wenger has traditionally employed that would even suggest such a player would make sense as a starter... too slow, too inefficient and way too easily dispossessed... once again, I think he has some special skills and, at times, has showed some world - class qualities but he's lack of mobility is an albatross around the necks of our offence... so when you ask who would be our best starting 11, I don't have a clue because of the 5 or 6 players that truly deserve a place in this side, 1 just arrived, 3 aren't under contract beyond 2018 and the other was just sold to Juve... man, this is theraputic because following this team is like an addiction to heroin without the benefits
The workshop featured presentations from invited speakers and discussions to highlight research findings that advance our understanding of the effects of maternal care services in different types of institutional settings on maternal labor, clinical and other birth procedures, and birth outcomes.
She visits OBGYN, perinatal, urology, family practice and internal medicine offices to educate them on The Fertility Center of Las Vegas by providing information on the practice, advances in reproductive endocrinology and infertility, new clinical trial research, success rates and other important information.
As part of a major medical center, we can offer our young patients evaluation and treatment that includes access to state - of - the - art equipment, advanced therapies, clinical trials and a team of specialists in pulmonology and from other clinical disciplines.
It became increasingly important to me to foster these ideas, so it was frustrating to learn that my dream of combining work in clinical medicine and bioethics was not supported by the German system of academic medicine — in contrast to the Anglo - American system and that in other advanced countries.
Other UT Southwestern faculty members who contributed to this research are: Dr. Boning Gao, Assistant Professor with the Hamon Center for Therapeutic Oncology Research and Pharmacology; Dr. Kimmo Hatanpaa, Associate Professor of Pathology; Dr. Kemp Kernstine, Professor of Cardiovascular and Thoracic Surgery and holder of the Robert Tucker Hayes Foundation Distinguished Chair in Cardiothoracic Surgery; Dr. Yang Xie, Associate Professor of Clinical Sciences and Bioinformatics; Dr. Hong Zhu, Assistant Professor of Clinical Sciences and with the Simmons Cancer Center; Dr. Farjana Fattah, Assistant Professor with the Simmons Cancer Center and Pathology; Dr. Masaya Takahashi, Associate Professor with the Advanced Imaging Research and Radiology; Dr. Bipasha Mukherjee, Assistant Professor of Radiation Oncology; Dr. Sandeep Burma, Associate Professor of Radiation Oncology; and Dr. Jonathan Dowell, Professor of Internal Medicine;
«We were surprised to find so many similarities between these two diseases, but most striking was that some of these common signatures are shared with other conditions like diabetic retinopathy and age - related macular degeneration,» said William A. Beltran, senior author on the study, an associate professor of ophthalmology in Penn Vet's Department of Clinical Sciences and Advanced Medicine and director of the Division of Experimental Retinal Therapies.
«Our findings are encouraging, as they suggest that entolimod can be safely combined with other chemotherapeutic, targeted or immunotherapeutic agents as treatment for advanced and very hard - to - treat cancers,» notes Dr. Adjei, who is Senior Vice President of Clinical Research and the Katherine Anne Gioia Chair in Cancer Medicine at Roswell Park.
«Considering that there is currently no clinical screening tool other than family history, this is a significant advance for development of molecular diagnostic tests,» she said.
«Considering that there is currently no clinical screening tool other than family history, this is a significant advance for development of molecular diagnostic tests,» Iyengar said.
To address the urgent need for therapies, researchers supported by the National Institutes of Health screened a set of 290 compounds already approved by the U.S. Food and Drug Administration or far advanced in clinical development for other indications to determine if any might also show potential for working against MERS - CoV.
A special section in the current issue of Clinical Scholars Review, the journal of advanced practice nursing published by Columbia Nursing, explores how the Affordable Care Act (ACA) empowers CRNAs to help make anesthesia services more accessible to patients, while also highlighting laws in New York and other states that may impede the expanded access to care envisioned by ACA.
«This methodology can serve as an advanced strategy to analyze the accuracy - dose tradeoff for other imaging systems, imaging technologies, or clinical tasks.»
Many factors may cause differences between current expectations and actual results including unexpected safety or efficacy data observed during preclinical or clinical studies, clinical trial site activation or enrollment rates that are lower than expected, changes in expected or existing competition, changes in the regulatory environment, failure of Syndax's collaborators to support or advance collaborations or product candidates and unexpected litigation or other disputes.
Collaborating with other academic researchers to advance clinical research in areas of high unmet medical need
A Phase 1b / 2 Open - Label Study to Evaluate Safety, Clinical Activity, Pharmacokinetics and Pharmacodynamics of Avelumab (MSB0010718C) in Combination with Other Cancer Immunotherapies in Patients with Advanced Malignancies
These forward - looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct preclinical development of its drug candidates and advance such candidates into clinical development, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as those relating to manufacturing, the regulatory process, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward - looking statements.
For more information regarding Bristol - Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: • Early stage IB - IIIA, operable non-small cell lung cancer, confirmed in tissue • Lung function capacity capable of tolerating the proposed lung surgery • Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 - 1 • Available tissue of primary lung tumor Exclusion Criteria: • Presence of locally advanced, inoperable or metastatic disease • Participants with active, known or suspected autoimmune disease • Prior treatment with any drug that targets T cell co-stimulations pathways (such as checkpoint inhibitors) Other protocol defined inclusion / exclusion criteria could apply
Addressing basic research, clinical diagnostics, drug discovery, environmental, food and beverage, forensics, and other markets, American Laboratory combines in - depth articles, news, and video to deliver the latest advances in their fields to thousands of print and online subscribers.
NCT02650986), which is open to adult patients with various types of advanced cancer whose tumors express NY - ESO - 1, or other clinical trials available at Roswell Park, please call 1 -800-ROSWELL (1-800-767-9355) or send an e-mail inquiry to [email protected].
Our team of fellowship - trained cardiothoracic surgeons, clinical fellows, residents, advanced trained nurses and physician assistants, specially trained intensivists and other health care professionals provides around - the - clock care that is unparalleled in North Carolina and in the region.
As one of the National Cancer Institute's designated cancer centers, Rutgers Cancer Institute of New Jersey is able to provide access to clinical trials not available at other hospitals, clinics or doctor's offices, as well as access to some of the most advanced, targeted treatments and medicines available.
Study using disabled form of HIV in gene therapy wins highest award from Clinical Research Forum; others cited for advances revealing damage caused by long - term cortisone shots to treat arthritic knees; and gene replacement therapy for infants with deadly neuromuscular disease
Leverages advanced technologies to investigate infectious diseases, human and other mammalian microbiomes, and their clinical impact.
Clinical responses in lung cancer patients have been impressive, with responses in patients with advance disease whose cancers did not respond to other treatment approaches.
«Advancing precision medicine with an NGS - based companion diagnostic test to support multiple NSCLC drug therapies» «Successes, challenges and future directions in other areas of clinical research»
Rutgers Cancer Institute along with its partner RWJBarnabas Health, offers patients access to the most advanced treatment options including clinical trials and novel therapeutics such as precision medicine, and immunotherapy — many of which are not available at other facilities across the state.
«We anticipate,» says Dr. Chou, «that this research will provide important pre-clinical data to support clinical trials using DAC and similar drugs combined with immune therapies targeting antigens like NY - ESO - 1 to treat advanced colorectal cancer and potentially other common cancers.»
The HudsonAlpha Clinical Services Lab, in collaboration with Illumina, serves as the whole genome sequencing core for the Undiagnosed Disease Network (UDN), a National Institutes of Health - funded study to diagnosed rare and new diseases through the use of genomics and other advanced technologies.
Currently, the CDK9 inhibitor flavopiridol is being evaluated in several phase I and II clinical trials for its anti-cancer effects either as a single agent or in combination with other drugs in treatment of esophageal cancer, B - cell chronic lymphocytic leukemia, endometrial carcinoma, recurrent / metastatic squamous cell carcinoma and most relevantly, previously treated locally advanced or metastatic breast cancer (http://www.cancernetwork.com/review-article/current-clinical-trials-flavopiridol/page/0/2).
Her current role focuses on advancing the use of whole genome sequencing in clinical care by providing access and education to healthy individuals through the... Understand Your Genome programs, MyGenome visualization software, and other research initiatives.
We welcomed international scientists, physicians, nutritionists, dieticians and other health professionals to showcase the latest advances from basic science, epidemiology clinical trials in vegetarian nutrition.
They publish full - length regular articles reporting the results of clinical trials or other experimental procedures, as well as short communications on minor advances in the field and reviews covering topics of special interest.
Ross owns Clinical Care Consultants, an Arlington Heights and Inverness IL counseling center and Advanced Clinical Trainers where his seminar / training work is available, and that of others.
Additionally, when teacher preparation includes high - quality clinical training, it provides an opportunity for veteran teachers to advance along a career pathway other than a position in administration — assuming leadership roles by becoming mentor teachers.
These three projects and two others were recently highlighted in an AACTE webinar held November 15, «Advancing Science and Math Teaching in Diverse Elementary Classrooms: A Clinical Practice Model at San Francisco State University.»
UC Davis veterinarians, led by Drs. Mathieu Spriet and Pablo Espinosa, are making breakthroughs in their discoveries of the diagnostic capabilities of positron emission tomography (PET) through a clinical trial and other research focused on advancing the clinical applications of this new modality.
UC Davis veterinarians, led by Drs. Mathieu Spriet and Pablo Espinosa, are continuing to see successes in their discoveries of the diagnostic capabilities of PET through this clinical trial and other research focused on advancing the clinical applications of this new modality.
The small animal rotating internship at Purdue University is a 12.5 - month clinical program (0.5 month orientation and 12 months clinical training) providing advanced clinical training in medicine, surgery, emergency medicine, and other specialties on an elective basis.
Therefore, you must emphasize all aspects of your talent, competence, and motivation such as work experience, community leadership, clinical programs and other advanced degrees.
In addition, those with a master's degree or other advanced degrees, and those candidates who have experience in a supervised clinical setting will be the most sought after.
For instance, while working at Standard Hospital as a Clinical Practicum in Acute Care, I have gained a deep understanding of how to perform emergency medical procedures such as basic and advanced cardiac life support, as well as other condition stabilizing interventions.
Interact with other clinical care and support professionals including psychologists, speech pathologists and occupational therapists to further advance class methodology.
This includes: (1) Involvement with multiple drug distribution functions (inclusive of computerized physician order entry and / or prospective review and verification of physicians» orders, IV admixture preparation, etc.)(2) Defined clinical activities to optimize therapeutic outcomes under the guidance of the departmental and corporate directives (which include active communication with physicians, nurses, and other healthcare staff about the need to clarify and / or change an order along with documentation of intervention outcomes)(3) Educational activities with pharmacist colleagues and other health care professionals (e.g., physicians, nurses, etc.) to maintain and advance clinical competencies (4) Supervise and provide oversight and direction of technicians» drug preparation and distribution activities to assure safe and expedient provision of pharmaceutical care to patients and staff.
The struggle to meet the increasing demand for psychological therapies, particularly during financial downturns, has driven interest in how therapies can be delivered more efficiently and effectively.3 Computerised cognitive behaviour therapy (cCBT) is a rapidly advancing field that has been recommended within National Institute for Health and Care Excellence (NICE) clinical guidelines for depression.4 Proponents of cCBT have highlighted increased access for patients and the potential of these treatments to empower patients, 5, 6 while others have been sceptical that therapy can work in the absence of a therapeutic relationship with a professional.7
While qualified to practice independently, advanced clinical social workers seek case consultation and make referrals to other specialists when appropriate.
ABE markets the BCD through social media and other methods and supports the advanced practice of clinical social work through the online resources of ACSWA, the American Clinical Social Work Assoclinical social work through the online resources of ACSWA, the American Clinical Social Work AssoClinical Social Work Association.
He holds two Post-Graduate Certificates; one in Advanced Clinical Social Work and Individual Psychotherapy and the other in Group Psychotherapy.
Implications of affective neuroscience, attachment theory, and other advances in clinical knowledge for best practices in parenting education, psychoeducation, and child and family therapy